| miR-29 has a role in protecting the tumor suppressor A20 mRNA from degradation by HuR in sarcoma | sarcoma, |
| The miR-29s acted as tumour suppressors and directly targeted laminin-integrin signalling in head and neck squamous cell carcinoma. | HNSC, |
| our results suggest that the tumor suppressor microRNA, miR-29a, is one of the regulators of expression in metastatic prostate cancer. | prostate, |
| Downregulation of miR-29a was a frequent event in cervical squamous cell carcinoma and miR-29a acted as a tumor suppressor by directly targeting HSP47. | cervical, |
| identified miR-29a and miR-330-5p as two new tumor suppressive miRNAs that inhibit the expression of MUC1 oncogenic mucin in pancreatic cancer cells. | pancreatic, |
| miR-29a could act as a tumor suppressor in PTC by targeting AKT3 and that miR-29a may potentially serve as an anti-tumor agent in the treatment of papillary thyroid carcinoma. | thyroid, |
| Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma | HNSC, |
| Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma | lung, |
| Results suggest that miR-29a is an important regulator of tumor necrosis factor receptor 1 expression in breast cancer and functions as a tumor suppressor by targeting tumor necrosis factor receptor 1 to influence the growth of MCF-7 cell. | breast, |
| MicroRNA-29a functions as a potential tumor suppressor through directly targeting CDC42 in non-small cell lung cancer | lung, |
| Data show miR29a expression significantly downregulated in retinoblastoma (RB) tissues and cell lines, and provide evidence that miR29a exerts a tumor suppressor effect on RB by repressing STAT3. | retinoblastoma, |
| MicroRNA-29a Functions as a Tumor Suppressor and Increases Cisplatin Sensitivity by Targeting NRAS in Lung Cancer | lung, |
| miR-29a-3p can inhibit gastric cancer cells proliferation and metastasis by regulation HAS3 expression. These findings reveal a new mechanism by which, at least partially, miR-29a-3p may act as a candidate tumor suppressor. | gastric, |
| our results indicated that miR-29a worked as the tumor suppressor of cervical cancer via DNMT1-mediated methylation of tumor suppressor gene SOCS1, which suppressed NF-kappaB pathway for suppressing tumor cell proliferation, cell migration or invasion and accelerating apoptosis, although more in vivo evidences should be pursued to validate the proposed working model. | cervical, |
| microRNA-29a functions as a tumor suppressor in nasopharyngeal carcinoma 5-8F cells through targeting VEGF | nasopharyngeal,laryngeal, |
| miR-29a Is Repressed by MYC in Pancreatic Cancer and Its Restoration Drives Tumor-Suppressive Effects via Downregulation of LOXL2 | pancreatic, |
| MiR-29a function as tumor suppressor in cervical cancer by targeting SIRT1 and predict patient prognosis | cervical, |
| MicroRNA-29a functions as a tumor suppressor through targeting STAT3 in laryngeal squamous cell carcinoma | laryngeal, |
| This study, we performed a comprehensive analysis of putative human miRNA oncogenes and tumor suppressors. We found that miRNA oncogenes and tumor suppressors clearly show different patterns in function, evolutionary rate, expression, chromosome distribution, molecule size, free energy, transcription factors, and targets. | None |
| miR-29b functions as a tumor suppressor in TSCC, and the miR-29b/Sp1/PTEN/AKT axis might represent a potential therapeutic target for TSCC intervention | None |